Aperio Group’s CRISPR Therapeutics CRSP Stock Holding History

Aperio Group’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$435K	Buy
2020 Q2	–	Sell
2020 Q1	$229K	Buy
2019 Q4	$272K	Buy
2019 Q3	–	Sell
2019 Q2	$153K	Buy